Privileged Metallocene Catalysts for Asymmetric Synthesis

Lead Research Organisation: University of East Anglia
Department Name: Chemistry

Abstract

Bulky cobalt metallocenes have recently found application in a number of asymmetric transformations characterised by high enantioselectivity. The further development of this area is hampered by the absence of a general methodology for the synthesis of planar chiral derivatives. A general solution to this problem is proposed involving asymmetric desymmetrisation by either metal catalysed cross-coupling and/or enantioselective halogen-metal exchange. The resulting non-racemic products will be used for the synthesis of representative P, PN and PP ligands, and also for the generation of palladium based and 'organocatalytic' rearrangement catalysts for application in asymmetric synthesis.
 
Description Bulky cobalt metallocenes have recently found application in a number of asymmetric transformations characterised by high enantioselectivity. The further development of this area is hampered by the absence of a general methodology for the synthesis of planar chiral derivatives. A general solution to this problem is proposed involving asymmetric desymmetrisation by either metal catalysed cross-coupling and/or enantioselective halogen-metal exchange. The resulting non-racemic products will be used for the synthesis of representative P, PN and PP ligands. In addition, enantioselective palladation will be developed for the rapid assembly of new rearrangement catalysts for application in asymmetric synthesis.
Exploitation Route Catalysts developed have the potential to be used in several areas of organic chemistry for the discovery and manufacture of bioactive compounds.
Sectors Chemicals,Pharmaceuticals and Medical Biotechnology

 
Description New methodology was established for the synthesis of chiral organometallic structures that were in turn used for the synthesis of novel catalysts. These enable the highly selective synthesis of organic building blocks for the generation of bioactive compounds.
First Year Of Impact 2009
Sector Chemicals,Pharmaceuticals and Medical Biotechnology
Impact Types Cultural,Societal,Economic